Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Mar 23;312(7033):762–766. doi: 10.1136/bmj.312.7033.762

North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults. North of England Asthma Guideline Development Group.

PMCID: PMC2350463  PMID: 8605467

Full text

PDF
762

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey W. C., Richards J. M., Jr, Brooks C. M., Soong S. J., Windsor R. A., Manzella B. A. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990 Aug;150(8):1664–1668. [PubMed] [Google Scholar]
  2. Barnes N. C., Marone G., Di Maria G. U., Visser S., Utama I., Payne S. L. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993 Jun;6(6):877–885. [PubMed] [Google Scholar]
  3. Bellia V., Cibella F., Migliara G., Peralta G., Bonsignore G. Characteristics and prognostic value of morning dipping of peak expiratory flow rate in stable asthmatic subjects. Chest. 1985 Jul;88(1):89–93. doi: 10.1378/chest.88.1.89. [DOI] [PubMed] [Google Scholar]
  4. Bergmann K. C., Bauer C. P., Overlack A. A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma. Curr Med Res Opin. 1989;11(8):533–542. doi: 10.1185/03007998909110465. [DOI] [PubMed] [Google Scholar]
  5. Beskow R., Ericsson C. H., Grönneberg R., Sjögren I., Skedinger M. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma. Eur J Respir Dis. 1984 Oct;65(7):509–511. [PubMed] [Google Scholar]
  6. Billing B., Dahlqvist R., Hörnblad Y., Leideman T., Skareke L., Ripe E. Theophylline in maintenance treatment of chronic asthma: concentration-dependent additional effect to beta 2-agonist therapy. Eur J Respir Dis. 1987 Jan;70(1):35–43. [PubMed] [Google Scholar]
  7. Blumenthal M. N., Selcow J., Spector S., Zeiger R. S., Mellon M. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma. J Allergy Clin Immunol. 1988 Apr;81(4):681–687. doi: 10.1016/0091-6749(88)91038-x. [DOI] [PubMed] [Google Scholar]
  8. Boldy D. A., Ayres J. G. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. Respir Med. 1993 Oct;87(7):517–523. doi: 10.1016/0954-6111(93)90007-m. [DOI] [PubMed] [Google Scholar]
  9. Boyd G., Abdallah S., Clark R. Twice or four times daily beclomethasone dipropionate in mild stable asthma? Clin Allergy. 1985 Jul;15(4):383–389. doi: 10.1111/j.1365-2222.1985.tb03007.x. [DOI] [PubMed] [Google Scholar]
  10. Britton M. G., Earnshaw J. S., Palmer J. B. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Eur Respir J. 1992 Oct;5(9):1062–1067. [PubMed] [Google Scholar]
  11. Bronsky E. A., Kemp J. P., Orgel H. A., Bierman C. W., Tinkelman D. G., van As A., Liddle R. F. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Chest. 1994 Apr;105(4):1032–1037. doi: 10.1378/chest.105.4.1032. [DOI] [PubMed] [Google Scholar]
  12. Carson J. L., Strom B. L., Schinnar R., Duff A., Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med. 1991 Sep;91(3):223–228. doi: 10.1016/0002-9343(91)90119-i. [DOI] [PubMed] [Google Scholar]
  13. Castle W., Fuller R., Hall J., Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993 Apr 17;306(6884):1034–1037. doi: 10.1136/bmj.306.6884.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chapman K. R., Kesten S., Szalai J. P. Regular vs as-needed inhaled salbutamol in asthma control. Lancet. 1994 Jun 4;343(8910):1379–1382. doi: 10.1016/s0140-6736(94)92520-8. [DOI] [PubMed] [Google Scholar]
  15. Colacone A., Afilalo M., Wolkove N., Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993 Sep;104(3):835–841. doi: 10.1378/chest.104.3.835. [DOI] [PubMed] [Google Scholar]
  16. Cua-Lim F., Agbayani B. F., Lachica D. A double-blind comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in patients routinely using oral bronchodilators. Eur J Respir Dis Suppl. 1986;147:306–310. [PubMed] [Google Scholar]
  17. Dahl R., Lundback B., Malo J. L., Mazza J. A., Nieminen M. M., Saarelainen P., Barnacle H. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest. 1993 Nov;104(5):1352–1358. doi: 10.1378/chest.104.5.1352. [DOI] [PubMed] [Google Scholar]
  18. De Blaquiere P., Christensen D. B., Carter W. B., Martin T. R. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis. 1989 Oct;140(4):910–916. doi: 10.1164/ajrccm/140.4.910. [DOI] [PubMed] [Google Scholar]
  19. Ebden P., Jenkins A., Houston G., Davies B. H. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax. 1986 Nov;41(11):869–874. doi: 10.1136/thx.41.11.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Eccles M., Clapp Z., Grimshaw J., Adams P. C., Higgins B., Purves I., Russell I. North of England evidence based guidelines development project: methods of guideline development. BMJ. 1996 Mar 23;312(7033):760–762. doi: 10.1136/bmj.312.7033.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Edwards A. M., Stevens M. T. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J. 1993 Jan;6(1):35–41. [PubMed] [Google Scholar]
  22. Fabbri L., Burge P. S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., Parker C. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993 Aug;48(8):817–823. doi: 10.1136/thx.48.8.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fitzpatrick M. F., Mackay T., Driver H., Douglas N. J. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ. 1990 Dec 15;301(6765):1365–1368. doi: 10.1136/bmj.301.6765.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fugleholm A. M., Ibsen T. B., Laxmyr L., Svendsen U. G. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. Eur Respir J. 1993 Nov;6(10):1474–1478. [PubMed] [Google Scholar]
  25. Gagnon M., Côte J., Milot J., Turcotte H., Boulet L. P. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. Chest. 1994 Jun;105(6):1732–1737. doi: 10.1378/chest.105.6.1732. [DOI] [PubMed] [Google Scholar]
  26. Greco D. B., Negreiros E. B., Chaieb J. A., Ferreira-Lima P., Croce J. A multicentre double-blind group comparative trial of two dose levels of nedocromil sodium and placebo in the management of perennial extrinsic asthma. Eur J Respir Dis Suppl. 1986;147:323–326. [PubMed] [Google Scholar]
  27. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  28. Higgins B. G., Britton J. R., Chinn S., Jones T. D., Jenkinson D., Burney P. G., Tattersfield A. E. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis. 1989 Nov;140(5):1368–1372. doi: 10.1164/ajrccm/140.5.1368. [DOI] [PubMed] [Google Scholar]
  29. Hilton S., Sibbald B., Anderson H. R., Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet. 1986 Jan 4;1(8471):26–29. doi: 10.1016/s0140-6736(86)91904-5. [DOI] [PubMed] [Google Scholar]
  30. Hummel S., Lehtonen L. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet. 1992 Dec 19;340(8834-8835):1483–1487. doi: 10.1016/0140-6736(92)92750-a. [DOI] [PubMed] [Google Scholar]
  31. Jenkinson D., Davison J., Jones S., Hawtin P. Comparison of effects of a self management booklet and audiocassette for patients with asthma. BMJ. 1988 Jul 23;297(6643):267–270. doi: 10.1136/bmj.297.6643.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kleijnen J., ter Riet G., Knipschild P. Acupuncture and asthma: a review of controlled trials. Thorax. 1991 Nov;46(11):799–802. doi: 10.1136/thx.46.11.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Laursen L. C., Taudorf E., Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. Eur J Respir Dis. 1986 Jan;68(1):19–28. [PubMed] [Google Scholar]
  34. Littenberg B. Aminophylline treatment in severe, acute asthma. A meta-analysis. JAMA. 1988 Mar 18;259(11):1678–1684. [PubMed] [Google Scholar]
  35. Lorentzson S., Boe J., Eriksson G., Persson G. Use of inhaled corticosteroids in patients with mild asthma. Thorax. 1990 Oct;45(10):733–735. doi: 10.1136/thx.45.10.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lundback B., Alexander M., Day J., Hebert J., Holzer R., Van Uffelen R., Kesten S., Jones A. L. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler. Respir Med. 1993 Nov;87(8):609–620. doi: 10.1016/s0954-6111(05)80264-1. [DOI] [PubMed] [Google Scholar]
  37. Lundback B., Rawlinson D. W., Palmer J. B. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax. 1993 Feb;48(2):148–153. doi: 10.1136/thx.48.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Munch E. P., Taudorf E., Weeke B. Dose frequency in the treatment of asthmatics with inhaled topical steroid. Eur J Respir Dis Suppl. 1982;122:143–153. [PubMed] [Google Scholar]
  39. Murphy D. G., McDermott M. F., Rydman R. J., Sloan E. P., Zalenski R. J. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med. 1993 Aug 9;153(15):1784–1788. [PubMed] [Google Scholar]
  40. Neville R. G., Crombie I. K., McDevitt D. G. A double-blind placebo-controlled trial of theophylline in general practice. Br J Clin Pract. 1991 Spring;45(1):14–17. [PubMed] [Google Scholar]
  41. Nowak R. M., Pensler M. I., Sarkar D. D., Anderson J. A., Kvale P. A., Ortiz A. E., Tomlanovich M. C. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med. 1982 Feb;11(2):64–69. doi: 10.1016/s0196-0644(82)80298-9. [DOI] [PubMed] [Google Scholar]
  42. Orgel H. A., Meltzer E. O., Welch M. J., Kemp J. P. Inhaled albuterol powder for the treatment of asthma--a dose-response study. J Allergy Clin Immunol. 1985 Apr;75(4):468–471. doi: 10.1016/s0091-6749(85)80019-1. [DOI] [PubMed] [Google Scholar]
  43. Osman L. M., Abdalla M. I., Beattie J. A., Ross S. J., Russell I. T., Friend J. A., Legge J. S., Douglas J. G. Reducing hospital admission through computer supported education for asthma patients. Grampian Asthma Study of Integrated Care (GRASSIC). BMJ. 1994 Feb 26;308(6928):568–571. doi: 10.1136/bmj.308.6928.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Palmer J. B., Stuart A. M., Shepherd G. L., Viskum K. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms). Respir Med. 1992 Sep;86(5):409–417. doi: 10.1016/s0954-6111(06)80008-9. [DOI] [PubMed] [Google Scholar]
  45. Pearlman D. S., Chervinsky P., LaForce C., Seltzer J. M., Southern D. L., Kemp J. P., Dockhorn R. J., Grossman J., Liddle R. F., Yancey S. W. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med. 1992 Nov 12;327(20):1420–1425. doi: 10.1056/NEJM199211123272004. [DOI] [PubMed] [Google Scholar]
  46. Persson G., Gnosspelius Y., Anehus S. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily. Eur Respir J. 1988 Mar;1(3):223–226. [PubMed] [Google Scholar]
  47. Pierson W. E., LaForce C. F., Bell T. D., MacCosbe P. E., Sykes R. S., Tinkelman D. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol. 1990 Mar;85(3):618–626. doi: 10.1016/0091-6749(90)90102-a. [DOI] [PubMed] [Google Scholar]
  48. Quackenboss J. J., Lebowitz M. D., Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis. 1991 Feb;143(2):323–330. doi: 10.1164/ajrccm/143.2.323. [DOI] [PubMed] [Google Scholar]
  49. Rohr A. S., Siegel S. C., Katz R. M., Rachelefsky G. S., Spector S. L., Lanier R. A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm. Ann Allergy. 1987 Aug;59(2):107–109. [PubMed] [Google Scholar]
  50. Rowe B. H., Keller J. L., Oxman A. D. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med. 1992 Jul;10(4):301–310. doi: 10.1016/0735-6757(92)90007-k. [DOI] [PubMed] [Google Scholar]
  51. Salmeron S., Brochard L., Mal H., Tenaillon A., Henry-Amar M., Renon D., Duroux P., Simonneau G. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994 Jun;149(6):1466–1470. doi: 10.1164/ajrccm.149.6.8004299. [DOI] [PubMed] [Google Scholar]
  52. Salmeron S., Guerin J. C., Godard P., Renon D., Henry-Amar M., Duroux P., Taytard A. High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study. Am Rev Respir Dis. 1989 Jul;140(1):167–171. doi: 10.1164/ajrccm/140.1.167. [DOI] [PubMed] [Google Scholar]
  53. Silagy C., Mant D., Fowler G., Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994 Jan 15;343(8890):139–142. doi: 10.1016/s0140-6736(94)90933-4. [DOI] [PubMed] [Google Scholar]
  54. Stiksa G., Glennow C. Once daily inhalation of budesonide in the treatment of chronic asthma: a clinical comparison. Ann Allergy. 1985 Jul;55(1):49–51. [PubMed] [Google Scholar]
  55. Svendsen U. G., Frølund L., Heinig J. H., Madsen F., Nielsen N. H., Weeke B. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy. 1992 Apr;47(2 Pt 2):174–180. doi: 10.1111/j.1398-9995.1992.tb00960.x. [DOI] [PubMed] [Google Scholar]
  56. Tang J. L., Law M., Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994 Jan 1;308(6920):21–26. doi: 10.1136/bmj.308.6920.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tashkin D. P., Kroening R. J., Bresler D. E., Simmons M., Coulson A. H., Kerschnar H. A controlled trial of real and simulated acupuncture in the management of chronic asthma. J Allergy Clin Immunol. 1985 Dec;76(6):855–864. doi: 10.1016/0091-6749(85)90760-2. [DOI] [PubMed] [Google Scholar]
  58. Taylor D. R., Sears M. R., Herbison G. P., Flannery E. M., Print C. G., Lake D. C., Yates D. M., Lucas M. K., Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. doi: 10.1136/thx.48.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Toogood J. H., Baskerville J., Jennings B., Lefcoe N. M., Johansson S. A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis. 1984 May;129(5):723–729. doi: 10.1164/arrd.1984.129.5.723. [DOI] [PubMed] [Google Scholar]
  60. Willey R. F., Godden D. J., Carmichael J., Preston P., Frame M., Crompton G. K. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest. 1982 Jan;76(1):61–68. [PubMed] [Google Scholar]
  61. Wilson S. R., Scamagas P., German D. F., Hughes G. W., Lulla S., Coss S., Chardon L., Thomas R. G., Starr-Schneidkraut N., Stancavage F. B. A controlled trial of two forms of self-management education for adults with asthma. Am J Med. 1993 Jun;94(6):564–576. doi: 10.1016/0002-9343(93)90206-5. [DOI] [PubMed] [Google Scholar]
  62. Windsor R. A., Bailey W. C., Richards J. M., Jr, Manzella B., Soong S. J., Brooks M. Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health. 1990 Dec;80(12):1519–1521. doi: 10.2105/ajph.80.12.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wong C. S., Cooper S., Britton J. R., Tattersfield A. E. Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids. Clin Exp Allergy. 1993 May;23(5):370–376. doi: 10.1111/j.1365-2222.1993.tb00341.x. [DOI] [PubMed] [Google Scholar]
  64. Woodman K., Bremner P., Burgess C., Crane J., Pearce N., Beasley R. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin. 1993;13(2):61–69. doi: 10.1185/03007999309111534. [DOI] [PubMed] [Google Scholar]
  65. Wrenn K., Slovis C. M., Murphy F., Greenberg R. S. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med. 1991 Aug 15;115(4):241–247. doi: 10.7326/0003-4819-115-4-241. [DOI] [PubMed] [Google Scholar]
  66. van As A., Chick T. W., Bodman S. F., Storms W. W., Nathan R. A., Selner J. C., Koepke J. W., Townley R. G., Bewtra A. K., Nair N. A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report. Eur J Respir Dis Suppl. 1986;147:143–148. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES